DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Pitt B, Sutton NR, Wang Z. et al
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19.
Eur J Pharmacol 2021;
898: 173988
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.